Letter: Beyond Survival Benefit in CHANCE2311—Important Considerations in the Interpretation of TACE Combined With Immunotherapy in Advanced HCC

Alimentary Pharmacology & Therapeutics 2026 Open access

Read full text
Authors: Yinghan Chen, Caiyun Lu, Yan Xu, Zhidong Zang
DOI: 10.1111/apt.70686
Cited by: 1
References: 8

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers HER2/EGFR in Cancer Research Radiopharmaceutical Chemistry and Applications

Publication details

Journal / source
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Volume
64
Issue
5
Pages
701–702
Publication date
19 April 2026
Language
EN